CB2090 Drug Development 7.5 credits

Läkemedelsutveckling

The course of Drug Development focuses on the therapeutic drugs (i.e. large molecules, small molecules, peptides, viral vectors, cells), from their discovery / development until their commercialisation.

Show course information based on the chosen semester and course offering:

Offering and execution

No offering selected

Select the semester and course offering above to get information from the correct course syllabus and course offering.

Course information

Content and learning outcomes

Course contents *

The lectures will cover a broad range of aspects of drug development. It will give current examples from the pharmaceutical industry and will mainly be given by invited guest lecturers. Topics to be covered are:

  • Classification of active substances and their pharmaceutical properties: proteins including antibodies and derived products, polymer molecules, small molecules, peptides, viral vectors and cells.
  • Basic pharmacology about administration, absorption, distribution and elimination, as well as pharmacokinetics and pharmacodynamics
  • Methods for target identification and validation for drug development, including bioinformatics/genomics
  • Methods for drug development such as screening, computer based calculations, in silico drug design and ADMET prediction
  • Safety and efficacy requirements as well as the methods used in pre-clinical studies and clinical trials of new pharmaceutical drugs
  • Market landscape for the different types of drugs and their therapeutic areas
  • Entrepreneurship and development of newly established research companies
  • Intellectual property protection in the context of drug development and commercialisation
  • Methods for commercial production of active substances
  • Methods for pharmaceutical drug delivery including nano particles

The students will be required to perform a literature task covering many aspects of the course, present a report, perform peer reviewing, hold an oral presentation and perform opposition. (This is a group assignment with individual reports).

Intended learning outcomes *

After successful completion of the course, the student should be able to:

  • Describe the different classes of pharmaceutical substances: proteins and other large molecules, small organic molecules, peptides, viral vectors and cells, with regards to their properties, production, safety and therapeutic areas
  • Describe and discuss the steps and important concepts in drug discovery and development, from target validation to commercial introduction of new therapeutic drugs, including the methods used in this field
  • Explain what is meant by administration, absorption, distribution and elimination, as well as pharmacodynamic and pharmacokinetic, and their implication in the development of new therapeutic drugs
  • Describe how the market landscape is for the different types of drugs and their therapeutic areas, and describe how this market has evolved this last century
  • Describe the studies and methods used to test the drugs before they are applied to human and in clinical trials
  • Give an account of- and explain how the therapeutic drugs are commercially produced, including the administration routes and delivery systems
  • Describe how the safety issues, the authority regulation and intellectual property aspects impact the process of drug discovery and development
  • Give an account of the use of computer based methods, including bioinformatics and genomics in drug discovery and development

Course Disposition

No information inserted

Literature and preparations

Specific prerequisites *

No information inserted

Recommended prerequisites

No information inserted

Equipment

No information inserted

Literature

No information inserted

Examination and completion

Grading scale *

A, B, C, D, E, FX, F

Examination *

  • LIT1 - Literature assignment, 2.0 credits, Grading scale: P, F
  • TEN1 - Written exam, 5.5 credits, Grading scale: P, F

Based on recommendation from KTH’s coordinator for disabilities, the examiner will decide how to adapt an examination for students with documented disability.

The examiner may apply another examination format when re-examining individual students.

Opportunity to complete the requirements via supplementary examination

No information inserted

Opportunity to raise an approved grade via renewed examination

No information inserted

Examiner

Amelie Eriksson Karlström

Further information

Course web

Further information about the course can be found on the Course web at the link below. Information on the Course web will later be moved to this site.

Course web CB2090

Offered by

CBH/Industrial Biotechnology

Main field of study *

Biotechnology

Education cycle *

Second cycle

Add-on studies

No information inserted

Ethical approach *

  • All members of a group are responsible for the group's work.
  • In any assessment, every student shall honestly disclose any help received and sources used.
  • In an oral assessment, every student shall be able to present and answer questions about the entire assignment and solution.